keyword
https://read.qxmd.com/read/38657273/tumor-tailored-ionizable-lipid-nanoparticles-facilitate-il-12-circular-rna-delivery-for-enhanced-lung-cancer-immunotherapy
#1
JOURNAL ARTICLE
Shufen Xu, Yue Xu, Nicholas C Solek, Jingan Chen, Fanglin Gong, Andrew James Varley, Alex Golubovic, Anni Pan, Songtao Dong, Gang Zheng, Bowen Li
The advancement of mRNA-based immunotherapies for cancer is highly dependent on the effective delivery of RNA payloads using ionizable lipid nanoparticles (LNPs). However, the clinical application of these therapies is hindered by variable mRNA expression among different cancer types and the risk of systemic toxicity. The transient expression profile of mRNA further complicates this issue, necessitating frequent dosing and thus increasing the potential for adverse effects. Addressing these challenges, we utilized a high-throughput combinatorial method to synthesize and screen LNPs that efficiently deliver circular RNA (circRNA) to lung tumors...
April 24, 2024: Advanced Materials
https://read.qxmd.com/read/38656878/keratin-6a-krt6a-promotes-radioresistance-invasion-and-metastasis-in-lung-cancer-via-p53-signaling-pathway
#2
JOURNAL ARTICLE
Qiang Xu, Ziyang Yu, Qiteng Mei, Kejun Shi, Jiaofeng Shen, Guangyu Gao, Songtao Liu, Ming Li
BACKGROUND: It is reported that the incidence rate and mortality of lung cancer are very high. Therefore, early diagnosis and identification of specific biomarkers are crucial for the clinical treatment of lung cancer. This study aims to comprehensively investigate the prognostic significance of KRT6A in human lung cancer. METHODS: The GEO2R online tool was utilized to analyze the differential expression of mRNA between lung carcinoma tissues and radioresistant tissues in the GSE73095 and GSE197236 datasets...
April 17, 2024: Aging
https://read.qxmd.com/read/38656658/bithiophene-functionalized-infrared-two-photon-absorption-metal-complexes-as-single-molecule-platforms-for-synergistic-photodynamic-photothermal-and-chemotherapy
#3
JOURNAL ARTICLE
Xue-Lian Li, Meng-Fan Wang, Li-Zhen Zeng, Guo-Kui Li, Run-Yu Zhao, Fu-Dan Liu, Yun Li, Yu-Fei Yan, Qishuai Liu, Zhao Li, Hongbin Zhang, Xiaoxia Ren, Feng Gao
A planar conjugated ligand functionalized with bithiophene and its Ru(II), Os(II), and Ir(III) complexes have been constructed as single-molecule platform for synergistic photodynamic, photothermal, and chemotherapy. The complexes have significant two-photon absorption at 808 nm and remarkable singlet oxygen and superoxide anion production in aqueous solution and cells when exposed to 808 nm infrared irradiation. The most potent Ru(II) complex Ru7 enters tumor cells via the rare macropinocytosis, locates in both nuclei and mitochondria, and regulates DNA-related chemotherapeutic mechanisms intranuclearly including DNA topoisomerase and RNA polymerase inhibition and their synergistic effects with photoactivated apoptosis, ferroptosis and DNA cleavage...
April 24, 2024: Angewandte Chemie
https://read.qxmd.com/read/38655365/pan-cancer-analysis-of-slc2a-family-genes-as-prognostic-biomarkers-and-therapeutic-targets
#4
JOURNAL ARTICLE
Yating Liu, Xinyu Li, Jie Yang, Shanshan Chen, Changyu Zhu, Yijun Shi, Shoutao Dang, Weitao Zhang, Wei Li
BACKGROUND: The major facilitator superfamily glucose transporters (GLUTs), encoded by solute carrier 2A (SLC2A) genes, mediate the transmembrane movement and uptake of glucose. To satisfy the improved energy demands, glycolysis flux is increased in cancers compared with healthy tissues. Multiple diseases, including cancer, have been associated with GLUTs. Nevertheless, not much research has been done on the functions of SLC2As in pan-cancer prognosis or their clinical treatment potential...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38654760/long-non-coding-rna-trg-as1-promoted-proliferation-and-invasion-of-lung-cancer-cells-through-the-mir-224-5p-smad4-axis-retraction
#5
(no author information available yet)
[This retracts the article DOI: 10.2147/OTT.S297336.].
2024: OncoTargets and Therapy
https://read.qxmd.com/read/38654325/tumor-suppressive-mir-4732-3p-is-sorted-into-fucosylated-exosome-by-hnrnpk-to-avoid-the-inhibition-of-lung-cancer-progression
#6
JOURNAL ARTICLE
Wanzhen Zhuang, Chengxiu Liu, Yilin Hong, Yue Zheng, Minjian Huang, Haijun Tang, Lilan Zhao, Zhixin Huang, Mingshu Tu, Lili Yu, Jianlin Chen, Yi Zhang, Xiongfeng Chen, Fan Lin, Qi Gao, Chundong Yu, Yi Huang
BACKGROUND: Aberrant fucosylation observed in cancer cells contributes to an augmented release of fucosylated exosomes into the bloodstream, where miRNAs including miR-4732-3p hold promise as potential tumor biomarkers in our pilot study. However, the mechanisms underlying the sorting of miR-4732-3p into fucosylated exosomes during lung cancer progression remain poorly understood. METHODS: A fucose-captured strategy based on lentil lectin-magnetic beads was utilized to isolate fucosylated exosomes and evaluate the efficiency for capturing tumor-derived exosomes using nanoparticle tracking analysis (NTA)...
April 23, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38652829/nanoparticle-retinoic-acid-inducible-gene-i-agonist-for-cancer-immunotherapy
#7
JOURNAL ARTICLE
Lihong Wang-Bishop, Mohamed Wehbe, Lucinda E Pastora, Jinming Yang, Blaise R Kimmel, Kyle M Garland, Kyle W Becker, Carcia S Carson, Eric W Roth, Katherine N Gibson-Corley, David Ulkoski, Venkata Krishnamurthy, Olga Fedorova, Ann Richmond, Anna Marie Pyle, John T Wilson
Pharmacological activation of the retinoic acid-inducible gene I (RIG-I) pathway holds promise for increasing tumor immunogenicity and improving the response to immune checkpoint inhibitors (ICIs). However, the potency and clinical efficacy of 5'-triphosphate RNA (3pRNA) agonists of RIG-I are hindered by multiple pharmacological barriers, including poor pharmacokinetics, nuclease degradation, and inefficient delivery to the cytosol where RIG-I is localized. Here, we address these challenges through the design and evaluation of ionizable lipid nanoparticles (LNPs) for the delivery of 3p-modified stem-loop RNAs (SLRs)...
April 23, 2024: ACS Nano
https://read.qxmd.com/read/38651918/codelivery-of-cpt-and-siphb1-with-gsh-ros-dual-responsive-hybrid-nanoparticles-based-on-a-12-anen-3-derived-lipid-for-synergistic-lung-cancer-therapy
#8
JOURNAL ARTICLE
Ya-Xuan Liang, Xue-Yi Sun, De-Zhong Xu, Yi-Nan Gao, Quan Tang, Zhong-Lin Lu, Yang Liu
The combination of small-interfering RNA (siRNA)-mediated gene silencing and chemotherapeutic agents for lung cancer treatment has attracted widespread attention in terms of a greater therapeutic effect, minimization of systemic toxicity, and inhibition of multiple drug resistance (MDR). In this work, three amphiphiles, CBN1 - CBN3 , were first designed and synthesized as a camptothecin (CPT) conjugate and gene condensation agents by the combination of CPT prodrugs and di(triazole-[12]aneN3 ) through the ROS-responsive phenylborate ester and different lengths of alkyl chains (with 6, 9, 12 carbon chains for CBN1 - CBN3 , respectively)...
April 23, 2024: ACS Applied Bio Materials
https://read.qxmd.com/read/38651061/bioinformatics-analysis-and-experimental-verification-of-tigd1-in-non-small-cell-lung-cancer
#9
JOURNAL ARTICLE
Lingchun Xia, Zhuofan Yang, Mingming Xv, Guohui Wang, Yaxin Mao, Yihan Yang, Jian Tang
INTRODUCTION: Non-small cell lung cancer (NSCLC) is a prevalent respiratory system tumor. Triggered transposable element derivative 1 (TIGD1) exhibits significant overexpression in various tumor cells and tissues, suggesting its involvement in cancer progression. METHODS: Clinical data and gene expression profiles of lung adenocarcinoma were collected from TCGA, UCSC XENA, and GEO databases. Computational techniques and empirical studies were employed to analyze the role of TIGD1 in NSCLC...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38649280/tumor-agnostic-transcriptome-based-classifier-identifies-spatial-infiltration-patterns-of-cd8-t-cells-in-the-tumor-microenvironment-and-predicts-clinical-outcome-in-early-phase-and-late-phase-clinical-trials
#10
JOURNAL ARTICLE
Andreas Roller, Iakov I Davydov, Petra C Schwalie, Martha L Serrano-Serrano, Astrid Heller, Nicolas Staedler, Cláudia S Ferreira, Gabriele Dietmann, Irina Klaman, Alberto Valdeolivas, Konstanty Korski, Michael A Cannarile
BACKGROUND: The immune status of a patient's tumor microenvironment (TME) may guide therapeutic interventions with cancer immunotherapy and help identify potential resistance mechanisms. Currently, patients' immune status is mostly classified based on CD8+tumor-infiltrating lymphocytes. An unmet need exists for comparable and reliable precision immunophenotyping tools that would facilitate clinical treatment-relevant decision-making and the understanding of how to overcome resistance mechanisms...
April 22, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38646640/lipid-nanoparticle-encapsulated-large-peritoneal-macrophages-migrate-to-the-lungs-via-the-systemic-circulation-in-a-model-of-clodronate-mediated-lung-resident-macrophage-depletion
#11
JOURNAL ARTICLE
Dhaval Oza, Fernando Ivich, Joshua Pace, Mikyung Yu, Mark Niedre, Mansoor Amiji
Rationale: A mature tissue resident macrophage (TRM) population residing in the peritoneal cavity has been known for its unique ability to migrate to peritoneally located injured tissues and impart wound healing properties. Here, we sought to expand on this unique ability of large peritoneal macrophages (LPMs) by investigating whether these GATA6+ LPMs could also intravasate into systemic circulation and migrate to extra-peritoneally located lungs upon ablating lung-resident alveolar macrophages (AMs) by intranasally administered clodronate liposomes in mice...
2024: Theranostics
https://read.qxmd.com/read/38646155/phosphoproteomic-analysis-identified-mutual-phosphorylation-of-fak-and-src-as-a-mechanism-of-osimertinib-resistance-in-egfr-mutant-lung-cancer
#12
JOURNAL ARTICLE
Takehiro Tozuka, Rintaro Noro, Keisuke Yoshida, Satoshi Takahashi, Mariko Hirao, Kuniko Matsuda, Yasuhiro Kato, Shinji Nakamichi, Susumu Takeuchi, Masaru Matsumoto, Akihiko Miyanaga, Shinobu Kunugi, Kazufumi Honda, Jun Adachi, Masahiro Seike
INTRODUCTION: Osimertinib is a standard treatment for patients with EGFR -mutant NSCLC. Although some osimertinib resistance mechanisms have been identified, nearly 50% of the mechanisms remain to be elucidated. This study was aimed at identifying non-genetic mechanisms underlying osimertinib resistance. METHODS: We established two osimertinib-resistant cell lines from EGFR mutation-positive PC-9 and HCC827 NSCLC cell lines (PC-9OR and HCC827OR, respectively) using a stepwise method...
April 2024: JTO clinical and research reports
https://read.qxmd.com/read/38645664/mechanism-of-musashi2-affecting-radiosensitivity-of-lung-cancer-by-modulating-dna-damage-repair
#13
JOURNAL ARTICLE
Hongjin Qu, Xiong Shi, Ying Xu, Hongran Qin, Junshi Li, Shanlin Cai, Jianpeng Zhao, Bingbing Wan, Yanyong Yang, Bailong Li
Identifying new targets for overcoming radioresistance is crucial for improving the efficacy of lung cancer radiotherapy, given that tumor cell resistance is a leading cause of treatment failure. Recent research has spotlighted the significance of Musashi2 (MSI2) in cancer biology. In this study, we first demonstrated that MSI2 plays a key function in regulating the radiosensitivity of lung cancer. The expression of MSI2 is negatively correlated with overall survival in cancer patients, and the knockdown of MSI2 inhibits tumorigenesis and increases radiosensitivity of lung cancer cells...
May 2024: MedComm
https://read.qxmd.com/read/38645169/respiratory-viral-infection-promotes-the-awakening-and-outgrowth-of-dormant-metastatic-breast-cancer-cells-in-lungs
#14
Shi B Chia, Bryan J Johnson, Junxiao Hu, Roel Vermeulen, Marc Chadeau-Hyam, Fernando Guntoro, Hugh Montgomery, Meher Preethi Boorgula, Varsha Sreeka, Andrew Goodspeed, Bennett Davenport, Felipe V Pereira, Vadym Zaberezhnyy, Wolfgang E Schleicher, Dexiang Gao, Andreia N Cadar, Michael Papanicolaou, Afshin Beheshti, Stephen B Baylin, James Costello, Jenna M Bartley, Thomas E Morrison, Julio A Aguirre-Ghiso, Mercedes Rincon, James DeGregori
Breast cancer is the second most common cancer globally. Most deaths from breast cancer are due to metastatic disease which often follows long periods of clinical dormancy 1 . Understanding the mechanisms that disrupt the quiescence of dormant disseminated cancer cells (DCC) is crucial for addressing metastatic progression. Infection with respiratory viruses (e.g. influenza or SARS-CoV-2) is common and triggers an inflammatory response locally and systemically 2,3 . Here we show that influenza virus infection leads to loss of the pro-dormancy mesenchymal phenotype in breast DCC in the lung, causing DCC proliferation within days of infection, and a greater than 100-fold expansion of carcinoma cells into metastatic lesions within two weeks...
April 5, 2024: Research Square
https://read.qxmd.com/read/38644473/protac-ezh2-degrader-1-overcomes-the-resistance-of-podophyllotoxin-derivatives-in-refractory-small-cell-lung-cancer-with-leptomeningeal-metastasis
#15
JOURNAL ARTICLE
Min-Xing Shi, Xi Ding, Liang Tang, Wei-Jun Cao, Bo Su, Jie Zhang
BACKGROUND: Leptomeningeal metastasis (LM) of small cell lung cancer (SCLC) is a highly detrimental occurrence associated with severe neurological disorders, lacking effective treatment currently. Proteolysis-targeting chimeric molecules (PROTACs) may provide new therapeutic avenues for treatment of podophyllotoxin derivatives-resistant SCLC with LM, warranting further exploration. METHODS: The SCLC cell line H128 expressing luciferase were mutated by MNNG to generate H128-Mut cell line...
April 22, 2024: BMC Cancer
https://read.qxmd.com/read/38643157/trametinib-sensitizes-kras-mutant-lung-adenocarcinoma-tumors-to-pd-1-pd-l1-axis-blockade-via-id1-downregulation
#16
JOURNAL ARTICLE
Ander Puyalto, María Rodríguez-Remírez, Inés López, Irati Macaya, Elizabeth Guruceaga, María Olmedo, Anna Vilalta-Lacarra, Connor Welch, Sergio Sandiego, Silvestre Vicent, Karmele Valencia, Alfonso Calvo, Ruben Pio, Luis E Raez, Christian Rolfo, Daniel Ajona, Ignacio Gil-Bazo
BACKGROUND: The identification of novel therapeutic strategies to overcome resistance to the MEK inhibitor trametinib in mutant KRAS lung adenocarcinoma (LUAD) is a challenge. This study analyzes the effects of trametinib on Id1 protein, a key factor involved in the KRAS oncogenic pathway, and investigates the role of Id1 in the acquired resistance to trametinib as well as the synergistic anticancer effect of trametinib combined with immunotherapy in KRAS-mutant LUAD. METHODS: We evaluated the effects of trametinib on KRAS-mutant LUAD by Western blot, RNA-seq and different syngeneic mouse models...
April 20, 2024: Molecular Cancer
https://read.qxmd.com/read/38639616/elucidation-of-the-anti-lung-cancer-mechanism-of-xiao-ai-jiedu-prescription-based-on-network-pharmacology-and-molecular-docking
#17
JOURNAL ARTICLE
Jin-Shu Fang, Jian-Yi Huang, Liu Li, Ping-Ping Zhai, Mian-Hua Wu, Wen-Ting Li
OBJECTIVE: Network pharmacology is an emerging discipline that applies computational methods to understand drug actions and interactions with multiple molecular targets. Xiao'ai Jiedu is a valued traditional Chinese medicine preparation for which the mechanism of action is not yet established. This study aims to explore the mechanism of Xiao'ai Jiedu in treating lung cancer through network pharmacology. METHODS: First, the Traditional Chinese Medicine Systems Pharmacology (TCMSP) data platform was used to analyze the target treatment results of different medicinal materials in Mr...
April 18, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38639105/gli1-cells-contribute-to-vascular-remodeling-in-pulmonary-hypertension
#18
JOURNAL ARTICLE
Xuran Chu, Vahid Kheirollahi, Arun Lingampally, Prakash Chelladurai, Chanil Valasarajan, Ana Ivonne Vazquez-Armendariz, Stefan Hadzic, Ali Khadim, Oleg Pak, Stefano Rivetti, Jochen Wilhelm, Marek Bartkuhn, Slaven Crnkovic, Alena Moiseenko, Monika Heiner, Simone Kraut, Leila Sotoodeh, Janine Koepke, Guilherme Valente, Clemens Ruppert, Thomas Braun, Christos Samakovlis, Ioannis Alexopoulos, Mario Looso, Cho-Ming Chao, Susanne Herold, Werner Seeger, Grazyna Kwapiszewska, Xiaoying Huang, Jin-San Zhang, Soni Savai Pullamsetti, Norbert Weissmann, Xiaokun Li, Elie El Agha, Saverio Bellusci
BACKGROUND: The precise origin of newly formed ACTA2+ (alpha smooth muscle actin-positive) cells appearing in nonmuscularized vessels in the context of pulmonary hypertension is still debatable although it is believed that they predominantly derive from preexisting vascular smooth muscle cells (VSMCs). METHODS: Gli1 Cre-ERT2 ; tdTomato flox mice were used to lineage trace GLI1+ (glioma-associated oncogene homolog 1-positive) cells in the context of pulmonary hypertension using 2 independent models of vascular remodeling and reverse remodeling: hypoxia and cigarette smoke exposure...
April 19, 2024: Circulation Research
https://read.qxmd.com/read/38638425/altered-circular-rna-expressions-in-extracellular-vesicles-from-bronchoalveolar-lavage-fluids-in-mice-after-bacterial-infections
#19
JOURNAL ARTICLE
Heedoo Lee, Rokgi Hong, Yang Jin
Circular RNAs (circRNAs) are a class of transcripts that often are generated by back-splicing that covalently connects the 3'end of the exon to the 5'end. CircRNAs are more resistant to nuclease and more stable than their linear counterparts. One of the well-recognized roles of circRNAs is the miRNA sponging effects that potentially lead to the regulation of downstream proteins. Despite that circRNAs have been reported to be involved in a wide range of human diseases, including cancers, cardiovascular, and neurological diseases, they have not been studied in inflammatory lung responses...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38637790/implications-of-znf334-gene-in-lymph-node-metastasis-of-lung-scc-potential-bypassing-of-cellular-senescence
#20
JOURNAL ARTICLE
Khalil Khashei Varnamkhasti, Mehdi Moghanibashi, Sirous Naeimi
BACKGROUND: The primary goal of this work is to identify biomarkers associated with lung squamous cell carcinoma and assess their potential for early detection of lymph node metastasis. METHODS: This study investigated gene expression in lymph node metastasis of lung squamous cell carcinoma using data from the Cancer Genome Atlas and R software. Protein-protein interaction networks, hub genes, and enriched pathways were analyzed. ZNF334 and TINAGL1, two less explored genes, were further examined through in vitro, ex vivo, and in vivo experiments to validate the findings from bioinformatics analyses...
April 18, 2024: Journal of Translational Medicine
keyword
keyword
75238
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.